Appointments - Erwan Martin has been appointed Chief Financial Officer of Spineway, a position he has held since November 2024, replacing Myriam Denis. Erwan reports directly to Stéphane Le Roux, co-founding Chairman and CEO.

Erwan Martin has been appointed Chief Financial Officer of Spineway, a position he has held since November 2024, replacing Myriam Denis. Erwan reports directly to Stéphane Le Roux, co-founding Chairman and CEO.
Erwan Martin has been appointed Chief Financial Officer of Spineway, in this position since November 2024. Erwan Martin, 56, TBS Education (1990), EMBA finance (1990), has completed the following career path:

* 2024 : Spineway, Chief Financial Officer

* 2019 - 2024: YposKesi, Chief financial officer, company secretary

* 1993 - 2003: Syndex, Consultant

* 2017 : Cellnovo, Group Chief Financial Officer

* 2010 : Genomic Vision, Member of the Management Board

* 2008: Genomic Vision, Chief Financial and Development Officer

* 2003 : Cytomics Pharmaceuticals, Chief Financial Officer

* 2003 : Cytomics Pharmaceuticals, Member of the Board of Directors

Copyri

No comment

< Previous

Share :

Log In

Notebook / Appointments